Tumor lysis syndrome screening: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) No edit summary |
|||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
Screening for tumor lysis syndrome is not recommended. However, patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup. | [[Screening]] for tumor lysis syndrome is not recommended. However, patients with any hematologic [[malignancies]] or [[acute renal failure]] should be considered for tumor lysis syndrome workup. | ||
==Screening== | ==Screening== | ||
*Screening for tumor lysis syndrome is not recommended | *[[Screening]] for tumor lysis syndrome is not recommended.<ref name="JonesWill2015">{{cite journal|last1=Jones|first1=Gail L|last2=Will|first2=Andrew|last3=Jackson|first3=Graham H|last4=Webb|first4=Nicholas J A|last5=Rule|first5=Simon|title=Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology|journal=British Journal of Haematology|volume=169|issue=5|year=2015|pages=661–671|issn=00071048|doi=10.1111/bjh.13403}}</ref> | ||
*Patients with [[malignancies]] or [[acute renal failure]] should be considered for tumor lysis syndrome workup. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 18: | Line 17: | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
Latest revision as of 15:27, 17 June 2019
|
Tumor lysis syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tumor lysis syndrome screening On the Web |
|
American Roentgen Ray Society Images of Tumor lysis syndrome screening |
|
Risk calculators and risk factors for Tumor lysis syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Screening for tumor lysis syndrome is not recommended. However, patients with any hematologic malignancies or acute renal failure should be considered for tumor lysis syndrome workup.
Screening
- Screening for tumor lysis syndrome is not recommended.[1]
- Patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup.
References
- ↑ Jones, Gail L; Will, Andrew; Jackson, Graham H; Webb, Nicholas J A; Rule, Simon (2015). "Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology". British Journal of Haematology. 169 (5): 661–671. doi:10.1111/bjh.13403. ISSN 0007-1048.